Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patients

Nephrology Dialysis Transplantation

Volumn 18, Issue SUPPL. 3, 2003, Pages

  Yamamoto, Hiroyasu ^a   Katoh, Naohiko ^a   Takeyama, Hiroshi ^a   Ikeda, Masato ^a   Yokoyama, Keitaro ^a   Shigematsu, Takashi ^a   Kawaguchi, Yoshindo ^a   Hosoya, Tatsuo ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic renal failure; Haemorrhagic necrosis; Hyperparathyroidiusm; Maxacalcitol; Parathyroid gland

Indexed keywords

22 OXACALCITRIOL;

ADHESION; ARTICLE; BLEEDING; CASE REPORT; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; ECHOGRAPHY; ENDOCRINE SURGERY; HEMODIALYSIS; HEMODIALYSIS PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; NODULAR HYPERPLASIA; ORGAN SIZE; PARATHYROID FUNCTION; PARATHYROIDECTOMY; PERCUTANEOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; TISSUE INJURY; TISSUE NECROSIS;

CALCITRIOL; HUMANS; HYPERPARATHYROIDISM, SECONDARY; INJECTIONS, INTRALESIONAL; PARATHYROID GLANDS; RENAL DIALYSIS;

EID: 0037677258     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Drüeke TB. The pathogenesis of parathyroid gland hyperplasia in chronic renal failure. Kidney Int 1995; 48: 259-272
2. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest 1984; 74: 2136-2143
3. Fukagawa M, Kitaoka M, Yi H et al. Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patients. Nephron 1994; 68: 221-228
4. Fukagawa M, Kitaoka M, Tominaga Y, Akizawa T, Kurokawa K. Selective percutaneous ethanol injection therapy (PEIT) of the parathyroid in chronic dialysis patients: the Japanese strategy. Japanese Working Group on PEIT of Parathyroid, Tokyo. Jap Nephrol Dial Transplant 1999; 14: 2574-2577
5. Chudek J, Kokot F, Witkowicz J et al. No marked apoptosis of parathyroid cells after intraparathyroid injections of Calcijex - observation in a patient with tertiary hyperparathyroidism after successful renal transplantation. Nephrol Dial Transplant 2000; 15: 424-425
6. Fukagawa M, Kitaoka M, Kurokawa K. Resistance of the parathyroid glands to vitamin D in renal failure: implications for medical management. Kidney Int Suppl 1997; 62: S60-S64
7. Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993; 92: 1436-1443
8. Fukagawa M, Tominaga Y, Kitaoka M, Kakuta T, Kurokawa K. Medical and surgical aspects of parathyroidectomy. Kidney Int Suppl 1999; 73: S65-S69
9. Kakuta T, Fukagawa M, Fujisaki T et al. Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients. Am J Kidney Dis 1999; 33: 1091-1099